Articles that mention Pfizer -BoardProspects

Pfizer

0 Comments Leave a Comment

1-15 of 37 1 2 3 »
1. Mentioned In 37 Articles
2. Does Bristol-Myers Have a Plan B if Activists Scuttle its Celgene Buy?
  
  Explore Pharma News Mar 11 2019 BoardBlogs
  
  ...company could—and would—swallow a drugmaker of Bristol's size. Many of the best-equipped companies, including Pfizer and AbbVie, have come out against megadeals in recent weeks....
  Read Full Article
  
  Comment
  
  Mentions: Management Bristol-Myers Squibb risk
3. Mesa Labs Announces Changes in The Composition of Its Board of Directors
  
  Explore GlobeNewswire Mar 6 2019 BoardMoves
  
  ...elopment, Sales & Marketing, Technical Support and General Management. In her most recent experience, she led Pfizer’s Biosimilars business, growing global revenues from zero in 2015 to approximately $800 million today. ...
  Read Full Article
  
  Comment
  
  Mentions: Management CFO Pfizer
4. AstraZeneca Pays CEO Soriot Nearly $15M After 2018's Return to Growth. Will Investors Push Back?
  
  Explore Pharma News Mar 5 2019 BoardNews
  
  ...014 takeover attempt. Now, with AZ moving forward and launching promising new meds, he may be right about the Pfizer bid. Still, the company is still far short of its stated goal of $45 billion in sales by 2023, which So...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Investors stock options
5. Bristol-Myers Squibb has $2.2 Billion at Stake if its Deal to Acquire Celgene Falls Apart, and Opposition is Mounting
  
  Explore Business Insider Feb 28 2019 BoardNews
  
  ...trategy that will work. A lot is on the line: Including debt, the deal is the largest ever in pharma, topping Pfizer's 1999 acquisition of Warner-Lambert and last year's Takeda-Shire deal, according to Bloomberg News. If...
  Read Full Article
  
  Comment
  
  Mentions: Investment Management State Street
6. OMEICOS Therapeutics Strengthens Board of Directors with the Appointment of Christian Schetter
  
  Explore businesswire.com Feb 11 2019 BoardMoves
  
  ...h multiple financing rounds, a NASDAQ IPO and, following several significant pharma deals, to a trade sale to Pfizer in 2007. Before entering the life science industry, Christian was successfully performing academic rese...
  Read Full Article
  
  Comment
  
  Mentions: IPO Pfizer Scripps
7. Emergent BioSolutions Announces Appointment of Robert G. Kramer, Sr. to Its Board of Directors
  
  Explore GlobeNewswire Jan 24 2019 BoardMoves
  
  ...harmacia Corporation, which subsequently merged with the Upjohn Company in 1995 and eventually became part of Pfizer Inc. Mr. Kramer received an M.B.A. from Western Kentucky University and a B.S. in industrial management...
  Read Full Article
  
  Comment
  
  Mentions: Twitter CFO NYSE
8. Pharma Giant GlaxoSmithKline Signs Mega Deal With Pfizer That Could Change the Face of Global Healthcare
  
  Explore Business Insider Dec 19 2018 BoardNews
  
  ...rs and significant benefits to patients and consumers," said Emma Walmsley, chief executive of GSK. The Glaxo-Pfizer deal comes on a huge day for the pharmaceutical industry after Bloomberg reported that General Electric...
  Read Full Article
  
  Comment
  
  Mentions: IPO Sanofi General Electric
9. PhaseBio Appoints Edmund P. Harrigan to Board of Directors
  
  Explore P&T Community Dec 17 2018 BoardMoves
  
  ...hree decades of experience in the pharmaceutical industry to PhaseBio’s board. During his 18-year tenure with Pfizer, Dr. Harrigan held numerous leadership roles in business development, regulatory affairs and quality as...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Pfizer Edmund Harrigan
10. Activist Investor Elliott Has Taken Position in Germany's Bayer
  
  Explore SHARENET Dec 7 2018 BoardNews
  
  ...ues if they tried to buy the whole unit. Bayer ranks fifth in veterinary medicine, behind Zoetis , the former Pfizer unit, Elanco, formerly of Eli Lilly, unlisted Boehringer Ingelheim, which acquired animal health assets...
  Read Full Article
  
  Comment
  
  Mentions: Activist Investors Investors Sanofi
11. IASO BioMed Announces Addition of Four Members to Its Scientific Advisory Board
  
  Explore P&T Community Nov 13 2018 BoardMoves
  
  ... Mermelstein was the founder of Javelin Pharmaceuticals, Inc. (JAV), which was acquired by Hospira, Inc., now Pfizer. He has served as the CEO and President of Javelin, which has brought to market in Europe DylojectTM, a...
  Read Full Article
  
  Comment
  
  Mentions: Management Harvard Bloomberg
12. Pfizer's Long-Serving CEO Ian Read is Standing Down and Being Replaced by his Chief Operating Officer
  
  Explore Business Insider Oct 1 2018 BoardNews
  
  ...chief operating officer. After standing down as both CEO and chairman, Read will become executive chairman of Pfizer's board of directors. "It's been an honor to serve as Pfizer's CEO for the past eight years," Read said...
  Read Full Article
  
  Comment
  
  Mentions: Pfizer Albert Bourla Ian Read
13. Institutional Investors Call on Manufacturers to Oppose Attacks on Shareholder
  
  Explore Pensions & Investments Aug 31 2018 BoardNews
  
  ...ainability of the company," said a letter sent in July to Kirsten Lund-Jurgensen, executive vice president of Pfizer Inc. The letter's content was the same or similar to those sent to other corporations, including Exxon ...
  Read Full Article
  
  Comment
  
  Mentions: Corporate Governance Management Investors
14. Palleon Pharmaceuticals Appoints Lori Hu of Vertex Ventures HC to Board of Directors
  
  Explore businesswire.com Jun 21 2018 BoardMoves
  
  ...d development programs with a $47.6 million Series A financing from leading biotech venture investors SR One, Pfizer Ventures, Vertex Ventures HC, Takeda Ventures, and AbbVie Ventures. Learn more at www.palleonpharma.com...
  Read Full Article
  
  Comment
  
  Mentions: Bristol-Myers Squibb MBA Vertex
15. Arcturus Therapeutics Appoints Four New Directors and Reaches Settlement Agreement with Founder Joseph E. Payne
  
  Explore CNBC.com May 29 2018 BoardMoves
  
  ...ire Therapeutics, Inc.(GEMP), an early-stage cardiovascular drug company formed by a licensing agreement with Pfizer Inc. He also is Chairman of the Board of privately held ComHear Inc., a digital audio software and devi...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Leadership Corporate Governance
16. Despite 34% Cut, AstraZeneca Shareholders Still Don't Like CEO Soriot's £9.4M Pay
  
  Explore Pharma News May 21 2018 BoardNews
  
  ...s pay more closely to the financial targets he set back when he was scrambling to avoid a hostile takeover by Pfizer, namely the £45-billion-by-2023 revenue target he quoted to investors at the time. It’s not as if those...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Investors hostile takeover
17. 1-15 of 37 1 2 3 »

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Related Topics
1. Yahoo! Names Thompson CEO
  136 articles also mentioned Board of Directors
2. Shantanu Narayen Elected To Pfizer's Board Of Directors
  81 articles also mentioned CEO
3. Chrysler Adds Two to Board
  37 articles also mentioned AT&T
4. Molson Coors Adds Two to Board
  34 articles also mentioned Europe
5. Thompson Joins Microsoft Board
  31 articles also mentioned Johnson & Johnson
Quotes about Pfizer
1. We are pleased to welcome Shantanu Narayen to Pfizer's Board of Directors. He brings both leadership experience and a strong technology background to Pfizer's Board and will be an excellent asset to the company.
  Ian Read in Shantanu Narayen Elected To Pfizer's Board Of Directors
2. We are pleased to have Jim Smith join Pfizer's Board of Directors. He brings leadership and operational and international business experience to Pfizer's Board, and will be an excellent asset to the company.
  Ian Read in James C. Smith Elected to Pfizer’s Board of Directors
3. Amy is a recognized leader in the development and growth of global pharmaceutical businesses, and she will bring this expertise to our Board as we continue to build Alnylam as a leading biotechnology company. As the former General Counsel at Pfizer, Amy also brings deep legal expertise to our Board.
  In Alnylam Elects Amy Schulman to its Board of Directors

Mentioned In 37 Articles

Categories

BoardProspects Features:

Related Topics

Quotes about Pfizer